Neuren Pharmaceuticals Limited Stock Today
| NURPF Stock | USD 12.53 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 74
|
Neuren Pharmaceuticals is trading at 12.53 as of the 24th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 12.53. Neuren Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Neuren Pharmaceuticals Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of May 2022 and ending today, the 24th of April 2024. Click here to learn more.
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. The company was incorporated in 2001 and is based in Camberwell, Australia. Neuren Pharmaceutica operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 128.97 M outstanding shares. More on Neuren Pharmaceuticals Limited
Moving together with Neuren Pink Sheet
| 0.68 | CSLLY | CSL | PairCorr |
| 0.68 | CMXHF | CSL Limited | PairCorr |
Moving against Neuren Pink Sheet
| 0.74 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.68 | TSM | Taiwan Semiconductor Financial Report 18th of July 2024 | PairCorr |
| 0.67 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.67 | NONOF | Novo Nordisk AS | PairCorr |
| 0.6 | SGEN | Seagen Inc Earnings Call Tomorrow | PairCorr |
Neuren Pharmaceuticals Limited cannot be verified against its exchange. Apparently, Neuren Pharmaceuticals is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshNeuren Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Neuren Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Neuren Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Managing Director | Larry Glass |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Neuren Pharmaceuticals Limited [NURPF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 660.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Neuren Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Neuren Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Neuren Pharmaceuticals classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 128.97 M outstanding shares.
Neuren Pharmaceuticals Limited has accumulated about 31.09 M in cash with (9.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Check Neuren Pharmaceuticals Probability Of Bankruptcy
Neuren Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Neuren Pharmaceuticals market risk premium is the additional return an investor will receive from holding Neuren Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neuren Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Neuren Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Neuren Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.4 | |||
| Standard Deviation | 3.13 | |||
| Variance | 9.81 | |||
| Risk Adjusted Performance | (0.05) |
Neuren Stock Against Markets
Picking the right benchmark for Neuren Pharmaceuticals pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Neuren Pharmaceuticals pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Neuren Pharmaceuticals is critical whether you are bullish or bearish towards Neuren Pharmaceuticals Limited at a given time. Please also check how Neuren Pharmaceuticals' historical prices are related to one of the top price index indicators.
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Neuren Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Neuren Pharmaceuticals Corporate Directors
Neuren Pharmaceuticals corporate directors refer to members of a Neuren Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Neuren Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Neuren Pharmaceuticals' board members must vote for the resolution. The Neuren Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Bruce Hancox | Independent Non-Executive Director | Profile | |
| Patrick Davies | Non-Executive Independent Director | Profile | |
| Jenny Harry | Non-Executive Independent Director | Profile | |
| Dianne Angus | Non-Executive Independent Director | Profile |
How to buy Neuren Pink Sheet?
Before investing in Neuren Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Neuren Pharmaceuticals. To buy Neuren Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Neuren Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Neuren Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Neuren Pharmaceuticals Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Neuren Pharmaceuticals Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Neuren Pharmaceuticals Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Neuren Pharmaceuticals Limited?
The danger of trading Neuren Pharmaceuticals Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Neuren Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Neuren Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Neuren Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuren Pharmaceuticals Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Neuren Pink Sheet analysis
When running Neuren Pharmaceuticals' price analysis, check to measure Neuren Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuren Pharmaceuticals is operating at the current time. Most of Neuren Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Neuren Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuren Pharmaceuticals' price. Additionally, you may evaluate how the addition of Neuren Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |